thorns2roses

From the darkness to beauty.

  • Contributors

  • Monthly Poll

  • Please Subscribe

    Please subscribe to this blog to receive updates on new posts and information about this blog. We love to hear your feedback and comments!
  • Subscribe

  • Enter your email address to subscribe to this blog and receive notifications of new posts by email.

    Join 11 other followers

  • Top Clicks

    • None
  • Blog Stats

    • 20,479 hits

FDA Alert – Recall: Endocet (oxycodone / acetaminophen) Tablets, ( 10mg, 325mg ) – Some Bottles Contain Different Strength Tablets

Posted by 4love2love on July 24, 2011

June 27, 2011
ISSUE: Endo Pharmaceuticals  and FDA notified pharmacists and patients of a nationwide consumer level recall of Endocet (oxycodone/acetaminophen, USP) Tablets, 10 mg/325 mg  because some bottles may contain different strength tablets, resulting in  patients taking more than the intended acetaminophen dose. Unintentional administration of tablets with increased acetaminophen content may result in liver toxicity, especially in patients on other acetaminophen containing medications, patients with liver dysfunction, or people who consume more than 3 alcoholic beverages a day.

BACKGROUND: The affected lots were distributed between April 19, 2011 and May 10, 2011 directly to wholesalers who are located in the following states: AL, AZ, CA, CO, NY, OH, ND, PR, IL, KY, NH, NJ, LA, NC, MO, PA, FL and TN. These wholesalers may further distribute to other retailers and wholesalers nationwide. Lot numbers can be found on the side of the manufacturer’s bottle. Tablet descriptions and photographs are provided in the firm’s press release.

RECOMMENDATION: Consumers who have the affected product should stop using the product and contact Endo’s agent Stericycle at 1-866-723-2681 for return of the product.

Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA’s MedWatch Safety Information and Adverse Event Reporting Program:

  • Complete and submit the report Online: www.fda.gov/MedWatch/report.htm
  • Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178
Advertisements

Sorry, the comment form is closed at this time.

 
%d bloggers like this: